tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market
Advertisement

Ascletis Pharma, Inc. (1672) Ratios

Compare
9 Followers

Ascletis Pharma, Inc. Ratios

HK:1672's free cash flow for Q2 2025 was ¥0.11. For the 2025 fiscal year, HK:1672's free cash flow was decreased by ¥ and operating cash flow was ¥-176.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
14.57 16.58 23.52 28.93 38.36
Quick Ratio
14.53 16.54 23.33 28.31 37.56
Cash Ratio
12.63 2.35 22.84 27.43 36.79
Solvency Ratio
-1.90 -0.85 -2.87 -1.71 -2.75
Operating Cash Flow Ratio
-2.49 -1.02 -1.32 -1.62 -1.15
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 1.69B¥ 2.18B¥ 2.43B¥ 2.53B¥ 2.74B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.07 1.06 1.05 1.04 1.03
Debt Service Coverage Ratio
0.00 -875.63 -2.14K -1.38K -1.74K
Interest Coverage Ratio
0.00 -2.13K -1.67K -1.57K -1.16K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
3.86 2.55 8.67 14.72 14.91
Profitability Margins
Gross Profit Margin
36.21%45.92%-45.65%50.96%-67.13%
EBIT Margin
-17811.17%-255.44%-581.78%-258.72%-597.43%
EBITDA Margin
-17267.94%-222.79%-525.97%-220.29%-519.82%
Operating Profit Margin
-20533.50%-542.11%-485.89%-254.82%-446.93%
Pretax Profit Margin
-10937.77%-255.70%-582.07%-258.88%-597.81%
Net Profit Margin
-10937.77%-255.70%-677.97%-262.94%-748.70%
Continuous Operations Profit Margin
-10937.77%-255.70%-582.07%-258.88%-597.81%
Net Income Per EBT
100.00%100.00%116.47%101.57%125.24%
EBT Per EBIT
53.27%47.17%119.80%101.59%133.76%
Return on Assets (ROA)
-12.95%-5.81%-13.80%-7.14%-8.54%
Return on Equity (ROE)
-13.49%-6.18%-14.44%-7.41%-8.79%
Return on Capital Employed (ROCE)
-25.93%-13.05%-10.31%-7.15%-5.23%
Return on Invested Capital (ROIC)
-25.88%-13.02%-12.00%-7.26%-6.54%
Return on Tangible Assets
-13.02%-5.87%-13.89%-7.35%-8.80%
Earnings Yield
-3.08%-11.44%-8.06%-6.87%-10.40%
Efficiency Ratios
Receivables Turnover
5.79 14.13 2.27 1.43 1.31
Payables Turnover
75.40 47.16 25.13 35.77 62.90
Inventory Turnover
0.31 5.04 3.84 0.67 0.99
Fixed Asset Turnover
0.05 0.83 0.74 0.99 0.41
Asset Turnover
<0.01 0.02 0.02 0.03 0.01
Working Capital Turnover Ratio
<0.01 0.02 0.02 0.03 0.01
Cash Conversion Cycle
1.23K 90.49 241.64 788.70 639.27
Days of Sales Outstanding
62.99 25.83 161.10 254.52 277.60
Days of Inventory Outstanding
1.17K 72.40 95.07 544.39 367.47
Days of Payables Outstanding
4.84 7.74 14.52 10.20 5.80
Operating Cycle
1.23K 98.23 256.16 798.90 645.07
Cash Flow Ratios
Operating Cash Flow Per Share
-0.32 -0.13 -0.13 -0.13 -0.08
Free Cash Flow Per Share
-0.33 -0.15 -0.14 -0.14 -0.12
CapEx Per Share
<0.01 0.02 0.01 <0.01 0.04
Free Cash Flow to Operating Cash Flow
1.01 1.13 1.10 1.05 1.46
Dividend Paid and CapEx Coverage Ratio
-148.52 -7.52 -9.89 -20.41 -2.18
Capital Expenditure Coverage Ratio
-148.52 -7.52 -9.89 -20.41 -2.18
Operating Cash Flow Coverage Ratio
-72.92 -17.13 -33.62 -53.43 -53.50
Operating Cash Flow to Sales Ratio
-131.62 -2.55 -2.63 -1.91 -2.43
Free Cash Flow Yield
-3.73%-12.91%-3.45%-5.24%-4.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-32.46 -8.74 -12.41 -14.55 -9.62
Price-to-Sales (P/S) Ratio
3.55K 22.36 84.11 38.26 72.00
Price-to-Book (P/B) Ratio
4.49 0.54 1.79 1.08 0.85
Price-to-Free Cash Flow (P/FCF) Ratio
-26.82 -7.75 -29.01 -19.08 -20.34
Price-to-Operating Cash Flow Ratio
-26.97 -8.78 -31.94 -20.02 -29.68
Price-to-Earnings Growth (PEG) Ratio
-4.54 0.14 -0.14 0.52 -0.14
Price-to-Fair Value
4.49 0.54 1.79 1.08 0.85
Enterprise Value Multiple
-16.72 -7.48 -7.32 -2.65 1.06
Enterprise Value
6.82B 943.53M 2.08B 448.16M -192.43M
EV to EBITDA
-16.72 -7.48 -7.32 -2.65 1.06
EV to Sales
2.89K 16.67 38.51 5.83 -5.50
EV to Free Cash Flow
-21.79 -5.78 -13.28 -2.91 1.55
EV to Operating Cash Flow
-21.93 -6.54 -14.62 -3.05 2.27
Tangible Book Value Per Share
1.93 2.16 2.32 2.42 2.78
Shareholders’ Equity Per Share
1.94 2.18 2.34 2.49 2.87
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.16 -0.02 -0.25
Revenue Per Share
<0.01 0.05 0.05 0.07 0.03
Net Income Per Share
-0.27 -0.13 -0.34 -0.18 -0.25
Tax Burden
1.00 1.00 1.16 1.02 1.25
Interest Burden
0.61 1.00 1.00 1.00 1.00
Research & Development to Revenue
134.02 3.83 4.94 2.77 3.12
SG&A to Revenue
43.86 1.11 0.29 0.21 0.58
Stock-Based Compensation to Revenue
2.19 0.02 0.06 0.09 0.13
Income Quality
1.20 1.00 0.45 0.74 0.41
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis